Coverage
-
January 06, 2016
Pharmaceutical companies Endo and Depomed told a New Jersey federal court on Wednesday that they seek to dismiss all claims and counterclaims in their dormant fight over whether painkiller Opana ER infringes three Depomed patents for extended-release drug technology.
1 other articles on this case.
View all »